Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

04.10.2011 - Merck KGaA said it inked two agreements for collaboration of its Merck Serono division with Ono Pharmaceutical, Osaka, Japan to strengthen its multiple sclerosis and cancer...